HUP0004432A3 - Thermodynamically stable form of (r)-3-[[(4-fluorophenyl)sulphonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban) and pharmaceutical composition containing it - Google Patents

Thermodynamically stable form of (r)-3-[[(4-fluorophenyl)sulphonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban) and pharmaceutical composition containing it

Info

Publication number
HUP0004432A3
HUP0004432A3 HU0004432A HUP0004432A HUP0004432A3 HU P0004432 A3 HUP0004432 A3 HU P0004432A3 HU 0004432 A HU0004432 A HU 0004432A HU P0004432 A HUP0004432 A HU P0004432A HU P0004432 A3 HUP0004432 A3 HU P0004432A3
Authority
HU
Hungary
Prior art keywords
ramatroban
sulphonyl
carbazole
fluorophenyl
tetrahydro
Prior art date
Application number
HU0004432A
Other languages
English (en)
Original Assignee
Bayer Yakuhin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Yakuhin Ltd filed Critical Bayer Yakuhin Ltd
Publication of HUP0004432A2 publication Critical patent/HUP0004432A2/hu
Publication of HUP0004432A3 publication Critical patent/HUP0004432A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
HU0004432A 1997-12-24 1998-12-24 Thermodynamically stable form of (r)-3-[[(4-fluorophenyl)sulphonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban) and pharmaceutical composition containing it HUP0004432A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19757983A DE19757983A1 (de) 1997-12-24 1997-12-24 Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban)
PCT/JP1998/005844 WO1999033803A1 (en) 1997-12-24 1998-12-24 Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban)

Publications (2)

Publication Number Publication Date
HUP0004432A2 HUP0004432A2 (hu) 2001-06-28
HUP0004432A3 true HUP0004432A3 (en) 2002-10-28

Family

ID=7853457

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004432A HUP0004432A3 (en) 1997-12-24 1998-12-24 Thermodynamically stable form of (r)-3-[[(4-fluorophenyl)sulphonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban) and pharmaceutical composition containing it

Country Status (37)

Country Link
US (1) US6362214B1 (hu)
EP (1) EP1051398B1 (hu)
JP (2) JP3817668B2 (hu)
KR (1) KR100586350B1 (hu)
CN (1) CN1140510C (hu)
AR (1) AR013803A1 (hu)
AT (1) ATE263152T1 (hu)
AU (1) AU744242B2 (hu)
BG (1) BG65024B1 (hu)
BR (1) BR9814496A (hu)
CA (1) CA2313230A1 (hu)
CO (1) CO4970800A1 (hu)
DE (2) DE19757983A1 (hu)
DK (1) DK1051398T3 (hu)
ES (1) ES2218874T3 (hu)
GT (1) GT199800198A (hu)
HK (1) HK1034517A1 (hu)
HN (1) HN1998000186A (hu)
HU (1) HUP0004432A3 (hu)
ID (1) ID25446A (hu)
IL (1) IL136278A (hu)
IN (1) IN192932B (hu)
MY (1) MY116312A (hu)
NO (1) NO316618B1 (hu)
NZ (1) NZ504741A (hu)
PE (1) PE20000115A1 (hu)
PL (1) PL341359A1 (hu)
PT (1) PT1051398E (hu)
RU (1) RU2220137C2 (hu)
SI (1) SI1051398T1 (hu)
SK (1) SK285109B6 (hu)
TR (1) TR200001936T2 (hu)
TW (1) TW552258B (hu)
UA (1) UA66832C2 (hu)
UY (2) UY25324A1 (hu)
WO (1) WO1999033803A1 (hu)
ZA (1) ZA9811817B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2395120T3 (es) * 2006-12-20 2013-02-08 Cardoz Ab Combinación de pemirolast y ramotrobán para su uso en el tratamiento de transtornos inflamatorios
CA2675520A1 (en) * 2007-01-16 2008-07-24 Cardoz Ab New combination for use in the treatment of inflammatory disorders
WO2009007674A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast
CN101434571B (zh) * 2007-11-13 2012-05-30 杭州容立医药科技有限公司 环烷并[1,2-b]吲哚磺酰胺、其异构体或其盐的合成方法
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
CN103054857A (zh) * 2012-12-30 2013-04-24 北京阜康仁生物制药科技有限公司 一种以雷马曲班为活性成分的固体制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1015711B (zh) 1986-02-21 1992-03-04 拜尔公司 制备环烷并[1,2-b]吲哚-磺酰胺类化合物的方法
DE3631824A1 (de) 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
DE19506739A1 (de) 1995-02-27 1996-08-29 Bayer Ag [3-Amino]-tetrahydrocarbazol-propansäureester

Also Published As

Publication number Publication date
BR9814496A (pt) 2000-10-10
WO1999033803A1 (en) 1999-07-08
RU2220137C2 (ru) 2003-12-27
DE69822882D1 (en) 2004-05-06
ID25446A (id) 2000-10-05
SI1051398T1 (en) 2004-08-31
US6362214B1 (en) 2002-03-26
PT1051398E (pt) 2004-07-30
AR013803A1 (es) 2001-01-10
NZ504741A (en) 2002-10-25
AU1687499A (en) 1999-07-19
NO316618B1 (no) 2004-03-08
KR100586350B1 (ko) 2006-06-07
DE19757983A1 (de) 1999-07-01
CA2313230A1 (en) 1999-07-08
IL136278A0 (en) 2001-05-20
HUP0004432A2 (hu) 2001-06-28
JP4411269B2 (ja) 2010-02-10
BG65024B1 (bg) 2006-12-29
JP2001527067A (ja) 2001-12-25
CO4970800A1 (es) 2000-11-07
TW552258B (en) 2003-09-11
AU744242B2 (en) 2002-02-21
HK1034517A1 (en) 2001-10-26
ATE263152T1 (de) 2004-04-15
SK9752000A3 (en) 2001-02-12
KR20010033529A (ko) 2001-04-25
ES2218874T3 (es) 2004-11-16
DK1051398T3 (da) 2004-07-19
MY116312A (en) 2003-12-31
IN192932B (hu) 2004-06-12
JP3817668B2 (ja) 2006-09-06
SK285109B6 (sk) 2006-06-01
CN1282320A (zh) 2001-01-31
DE69822882T2 (de) 2005-02-03
TR200001936T2 (tr) 2001-01-22
NO20003217L (no) 2000-06-21
IL136278A (en) 2005-03-20
JP2006151977A (ja) 2006-06-15
PE20000115A1 (es) 2000-03-26
UY25324A1 (es) 2000-12-29
NO20003217D0 (no) 2000-06-21
UA66832C2 (uk) 2004-06-15
EP1051398B1 (en) 2004-03-31
CN1140510C (zh) 2004-03-03
UY25575A1 (es) 1999-11-17
ZA9811817B (en) 1999-06-29
BG104554A (en) 2001-05-31
GT199800198A (es) 1998-12-15
PL341359A1 (en) 2001-04-09
HN1998000186A (es) 1999-11-03
EP1051398A1 (en) 2000-11-15

Similar Documents

Publication Publication Date Title
ZA9811759B (en) Novel indole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them.
HUP9701554D0 (en) Pharmaceutical composition containing plazma proteins
AU3455297A (en) Pharmaceutical composition containing acid addition salt of basic drug
HK1025904A1 (en) Pharmaceutical composition for combination of piperidinoalkanol-decongestant
HUP0003844A3 (en) Novel spiroazabicyclic heterocyclic compounds, process for their preparation, their use and pharmaceutical compositions containing them
HUP9800813A3 (en) Lactam-containing hydroxamic acid derivatives, their preparation and pharmaceutical compositions containing them
HUP0100280A3 (en) Pyrrolo-, thieno-, furano- and pyrazolo- [3,4d]-pyridazinones, process for their preparation and pharmaceutical compositions containing them
HUP0001652A3 (en) Oxadiazole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them
HUP9801045A3 (en) Sulfonyl-amino-carboxylic acid derivatives, use thereof, pharmaceutical compositions containing them and process for their preparation
HK1025744A1 (en) Pharmaceutical formulation of omeprazole
HUP9801044A3 (en) Sulfonylamino-carboxylic acid derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0002830A3 (en) Indole and 2,3-dihydroindole derivatives, their preparation, use, and pharmaceutical compositions containing them
HUP0003198A2 (en) Thermodynamically stable modification of 1-(4-carbazoly-loxy)-3-[2-(2-(methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it
HUP0000960A3 (en) Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
HUP0004345A3 (en) Novel oral pharmaceutical compositions containing from carvedilol
IL114673A (en) Pharmaceutical compositions containing protein for oral administration
HUP0004432A3 (en) Thermodynamically stable form of (r)-3-[[(4-fluorophenyl)sulphonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban) and pharmaceutical composition containing it
AU3953197A (en) Catechol amino acid derivatives and pharmaceutical compositions containing them
HK1055947A1 (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1H-Ä1,2,4Ütriazol, methods for producing them and pharmaceutical compositions containing them
AU1930097A (en) Slow-release pharmaceutical formulations containing mizolastin
HUP0001873A3 (en) Amidino-1,4-benzoxazepine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
IL133826A0 (en) Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl) amino] methyl]amino]benzonitrile and pharmaceutical compositions containing the same
HUP0003104A3 (en) Amino-spiropiperidin-quinazoline derivatives, their use, process for their preparation and pharmaceutical compositions containing them
HUP0001183A3 (en) Pyrrolothiazine and pyrrolothiazepine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9800277A3 (en) N-(1,2,3,4-tetrahydro-naphthyl- and -quinolyl)sulfonamide derivatives, their use for preparation of pharmaceutical compositions and pharmaceutical compositions containing them